Plain-English translation of NCT07415720 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a daily artichoke by-product supplement rich in specific plant compounds called hydroxycinnamic acids can help prevent type 2 diabetes when combined with a Mediterranean diet. Researchers want to see if the medication works better than diet and exercise alone at improving how your body uses insulin and managing your weight. The study will last 16 weeks, and participants will be randomly assigned to either receive the artichoke supplement or a placebo (dummy pill) while following the same healthy eating and exercise plan.
Type 2 diabetes and obesity are major health problems, and while Mediterranean-style diets have helped many people, results vary from person to person. This trial explores whether the medication might enhance the benefits of a healthy diet by addressing insulin resistance at a deeper level, and whether certain people might respond better to this treatment based on their individual biology.
You likely qualify if…
You likely don't qualify if…
Over 16 weeks, you would attend study visits and follow a Mediterranean diet designed to reduce your daily calories by about 500 calories. You'll receive personalized guidance on healthy eating and be asked to exercise at least 150 minutes per week. Half of participants will take daily artichoke supplement capsules, and the other half will take identical-looking placebo capsules—neither you nor the researchers will know which you're receiving. You'll also provide blood samples so researchers can measure changes in your insulin levels, weight, and other markers of metabolic health.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Spain